Clobquin S3 Cream contains Clobetasol 0.05% w/w, a potent corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties, and Salicylic Acid 3% w/w, a keratolytic agent that softens and removes thickened skin layers. This combination is ideal for hyperkeratotic and inflammatory dermatological conditions.
Clinically, the cream is indicated for psoriasis, lichenified eczema, hyperkeratotic plaques, and chronic inflammatory dermatoses. Clobetasol reduces redness, itching, and swelling, while Salicylic Acid promotes gentle exfoliation and lesion resolution.
The cream formulation ensures uniform application, enhanced skin penetration, and sustained local therapeutic effect, making it suitable for dermatology clinics, hospitals, outpatient skin care centers, and pharmacies. Topical administration provides convenience, patient adherence, and localized action.
Clobquin S3 Cream helps in reducing inflammation, softening thickened skin, relieving irritation and scaling, and promoting faster skin recovery. Its proven clinical efficacy and safety under proper supervision make it a trusted anti-inflammatory and keratolytic therapy in dermatological practice.